Lataa...
The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex
The discovery of the hepatitis C virus (HCV) NS5A replication inhibitor daclatasvir (1) had its origins in a phenotypic screening lead. However, during the optimization campaign, it was observed that some members of the chemotype underwent a radical dimerization under the assay conditions. This redi...
Tallennettuna:
| Julkaisussa: | HCV: The Journey from Discovery to a Cure |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7122418/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/7355_2018_47 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|